Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-01-05 Trizzino John EVP, CMO and CBO Exercise or conversion · Stock Option (Right to Buy) −2,214 0
2021-01-05 Trizzino John EVP, CMO and CBO Exercise or conversion · Stock Option (Right to Buy) −1,668 5,009
2021-01-05 Trizzino John EVP, CMO and CBO Exercise or conversion · Stock Option (Right to Buy) −2,082 12,507
2021-01-05 Trizzino John EVP, CMO and CBO Exercise or conversion · Stock Option (Right to Buy) −6,249 68,751
2021-01-05 Trizzino John EVP, CMO and CBO Exercise or conversion · Stock Appreciation Right −1,149 12,651
2021-01-01 YOUNG JAMES F Director Exercise or conversion +10,000 10,000
2021-01-01 YOUNG JAMES F Director Exercise or conversion · Restricted Stock Units −10,000 10,000
2020-12-31 DOUGLAS RICHARD Director Exercise or conversion +1,000 $50.00 $50K 28,500
2020-12-31 DOUGLAS RICHARD Director Exercise or conversion · Stock Option (Right to Buy) −1,000 0
2020-12-31 YOUNG JAMES F Director Exercise or conversion +1,000 $50.00 $50K 1,000
2020-12-31 YOUNG JAMES F Director Exercise or conversion +10,000 $51.40 $514K 11,000
2020-12-31 YOUNG JAMES F Director Sale −9,000 $112.98 $1.0M 2,000
2020-12-31 YOUNG JAMES F Director Sale −2,000 $113.60 $227K 0
2020-12-31 YOUNG JAMES F Director Exercise or conversion · Stock Option (Right to Buy) −1,000 0
2020-12-31 YOUNG JAMES F Director Exercise or conversion · Stock Option (Right to Buy) −10,000 0
2020-12-14 Herrmann John A III EVP, Chief Legal Officer Grant or award · Stock Option (Right to Buy) +12,700 12,700
2020-12-14 Herrmann John A III EVP, Chief Legal Officer Grant or award · Restricted Stock Units +6,300 6,300
2020-12-14 Trizzino John EVP, CMO and CBO Grant or award · Stock Option (Right to Buy) +9,500 9,500
2020-12-14 Trizzino John EVP, CMO and CBO Grant or award · Restricted Stock Units +4,800 4,800
2020-12-14 Glenn Gregory M President, R&D Grant or award · Stock Option (Right to Buy) +18,700 18,700

Page 74 of 87 · 1,734 trades